The global upper respiratory tract infection treatment market reached USD 1.81 billion in 2024. With a projected CAGR of 3.60%, it is expected to reach approximately USD 2.58 billion by 2034. The increasing prevalence of respiratory infections and the development of targeted therapeutics contribute significantly to market growth. https://www.expertmarketresearch.com/reports/upper-respiratory-tract-infection-treatment-market